Germany, March 4 -- Germany based Sanofi-Aventis Deutschland GmbH has secured contract from AOK PLUS - Die Gesundheitskasse fur Sachsen und Thuringen for Pharmaceutical products - Agreement according to Section 130c Paragraph 1 SGB V for the drug Dupixent with the active ingredient Dupilumab. The value of the contract is not disclosed.
Published by HT Digital Content Services with permission from Pivotal Sources....